User login
Myelodysplastic syndromes: etiologies, evaluation, and therapy
In this interview, Dr David Henry, MD, the Editor-in-Chief of JCSO, and David Steensma, MD, of the Dana-Farber Cancer Institute in Boston, talk about myelodysplasic syndromes, from diagnosis, evaluation, and etiologies, to therapy options and molecular sequencing.
Listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interview.
In this interview, Dr David Henry, MD, the Editor-in-Chief of JCSO, and David Steensma, MD, of the Dana-Farber Cancer Institute in Boston, talk about myelodysplasic syndromes, from diagnosis, evaluation, and etiologies, to therapy options and molecular sequencing.
Listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interview.
In this interview, Dr David Henry, MD, the Editor-in-Chief of JCSO, and David Steensma, MD, of the Dana-Farber Cancer Institute in Boston, talk about myelodysplasic syndromes, from diagnosis, evaluation, and etiologies, to therapy options and molecular sequencing.
Listen to the podcast below, or click on the PDF icon at the top of this introduction to read a transcript of the interview.